Tocilizumab as an Adjuvant Therapy for Hemophagocytic Lymphohistiocytosis Associated with Visceral Leishmaniasis

American Journal of Therapeutics

Volumn 23, Issue 5, 2016, Pages e1193-e1196

  Rios Fernández, Raquel ^a   Callejas Rubio, Jose Luis ^a   García Rodríguez, Sonia ^b   Sancho, Jaime ^b   Zubiaur, Mercedes ^b   Ortego Centeno, Norberto ^a  

^a HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^b INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

Author keywords

hemophagocytic lymphohistiocytosis; interleukin 6; Leishmania; tocilizumab; visceral leishmaniasis

Indexed keywords

ADALIMUMAB; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; AMPHOTERICIN B LIPID COMPLEX; ANTIMONY GLUCONATE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CYCLOSPORIN; ETOPOSIDE; FERRITIN; FLUORODEOXYGLUCOSE; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN; IMMUNOGLOBULIN; INTERLEUKIN 6; ITRACONAZOLE; LACTATE DEHYDROGENASE; MILTEFOSINE; STEROID; TOCILIZUMAB; TRIACYLGLYCEROL; ZOLEDRONIC ACID; INTERLEUKIN 6 RECEPTOR; MONOCLONAL ANTIBODY;

ABDOMINAL PAIN; ADJUVANT THERAPY; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY TEMPERATURE; BONE MARROW; BONE MARROW BIOPSY; CANCER CHEMOTHERAPY; CASE REPORT; COLOMBIA; COLON; COLONOSCOPY; DIARRHEA; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROPHAGOCYTOSIS; FEMALE; FERRITIN BLOOD LEVEL; FEVER; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HEMOPHAGOCYTIC SYNDROME; HEPATOSPLENOMEGALY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LACTATE DEHYDROGENASE BLOOD LEVEL; LEISHMANIA; LEISHMANIASIS; LEUKOCYTE COUNT; LYMPHADENOPATHY; MEAN CORPUSCULAR VOLUME; MULTIPLE CYCLE TREATMENT; NIGHT SWEAT; PALLOR; PANCYTOPENIA; PHYSICAL EXAMINATION; PLASMACYTOSIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SINGLE DRUG DOSE; SPAIN; STEROID THERAPY; THROMBOCYTE COUNT; TRIACYLGLYCEROL BLOOD LEVEL; VISCERAL LEISHMANIASIS; ANTAGONISTS AND INHIBITORS; COMPLICATION; IMMUNOLOGY; LEISHMANIASIS, VISCERAL; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC;

ADULT; ANTIBODIES, MONOCLONAL, HUMANIZED; FEMALE; HUMANS; LEISHMANIASIS, VISCERAL; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; RECEPTORS, INTERLEUKIN-6;

EID: 84988360208     PISSN: 10752765     EISSN: 15363686     Source Type: Journal    
DOI: 10.1097/MJT.0000000000000035     Document Type: Article

References (15)

1. Henter JI, Horne A, Arico M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48: 124-131.
2. Brastianos PK, Swanson JW, Torbenson M, et al. Tuberculosis-associated haemophagocytic syndrome. Lancet Infect Dis. 2006;6:447-454.
3. Rajagopala S, Dutta U, Chandra KS, et al. Visceral leishmaniasis associated hemophagocytic lymphohistiocytosis-case report and systematic review. J Infect. 2008;56: 381-388.
4. Boelaert M, El-Safi S, Hailu A, et al. Diagnostic tests for kala-azar: A multi-centre study of the freeze-dried DAT, rK39 strip test and KAtex in East Africa and the Indian subcontinent. Trans R Soc Trop Med Hyg. 2008;102:32-40.
5. da Silva MR, Stewart JM, Costa CH. Sensitivity of bone marrow aspirates in the diagnosis of visceral leishmaniasis. Am J Trop Med Hyg. 2005;72:811-814.
6. Hide M, Singh R, Kumar B, et al. A microculture technique for isolating live Leishmania parasites from peripheral blood of visceral leishmaniasis patients. Acta Trop. 2007;102:197-200.
7. Minodier P, Piarroux R, Garnier JM, et al. Pediatric visceral leishmaniasis in southern France. Pediatr Infect Dis J. 1998;17:701-704.
8. Sanders JM, Gomez AO, Mao J, et al. 3-D QSAR investigations of the inhibition of Leishmania major farnesyl pyrophosphate synthase by bisphosphonates. J Med Chem. 2003;46:5171-5183.
9. Bouguila J, Chabchoub I, Moncef Y, et al. Treatment of severe hemophagocytic syndrome associated with visceral leishmaniasis. Arch Pediatr. 2010;17:1566-1570.
10. Murray HW. Accelerated control of visceral Leishmania donovani infection in interleukin-6-deficient mice. Infect Immun. 2008;76:4088-4091.
11. van der Poll T, Zijlstra EE, Mevissen M. Interleukin 6 during active visceral leishmaniasis and after treatment. Clin Immunol Immunopathol. 1995;77:111-114.
12. de Lima VM, Peiro JR, de Oliveira Vasconcelos R. IL-6 and TNF-alpha production during active canine visceral leishmaniasis. Vet Immunol Immunopathol. 2007; 115:189-193.
13. Beaman MH, Hunter CA, Remington JS. Enhancement of intracellular replication of Toxoplasma gondii by IL-6. Interactions with IFN-gamma and TNF-alpha. J Immunol. 1994;153:4583-4587.
14. Tanaka T, Narazaki M, Kishimoto T. Anti-interleukin-6 receptor antibody, tocilizumab, for the treatment of autoimmune diseases. FEBS Lett. 2011;585:3699-3709.
15. Kaly L, Rosner I. Tocilizumab-a novel therapy for nonorgan-specific autoimmune diseases. Best Pract Res Clin Rheumatol. 2012;26:157-165.